Skip to content

Microbiology, susceptibility, risk factors and clinical prognosis of Gram-negative bacteria in patients undergoing abdominal solid organ transplantation (ASOT): a retrospective study in Wuhan, China

Microbiology, susceptibility, risk factors and clinical prognosis of Gram-negative bacteria in patients undergoing abdominal solid organ transplantation (ASOT): a retrospective study in Wuhan, China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077702
Enrollment
Unknown
Registered
2023-11-16
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gram-negative bacteria in patients undergoing abdominal solid organ transplantation (ASOT)

Interventions

Group of liver transplant recipients infected with gram-negative bacteria:None
Group of liver transplant recipients without Gram negative bacterial infection:None
Group of renal transplant recipients with Gram negative bacterial infection:None
Group of renal transplant recipients without Gram negative bacterial infection:None

Sponsors

Tongji Hospital, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients who underwent donation after Citizen's death (DCD) between 2015 and 2023.

Exclusion criteria

Exclusion criteria: Recipients who were lost to follow-up or moved out of the hospital with 30 days or who were recipients of multiorgan transplants.

Design outcomes

Primary

MeasureTime frame
Donor Tissue Culture;Organ Preservation Solution Culture;

Secondary

MeasureTime frame
routine blood test;

Countries

China

Contacts

Public ContactDong Chen

Tongji Hospital, Huazhong University of Science and Technology

dchen0369@163.com+86 133 6726 3696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026